We are live on ! Find out more
NGNE icon

Neurogene
NGNE

63 hedge funds and large institutions have $21.4M invested in Neurogene in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.44% less ownership

Funds ownership: 2.89% → 2.45% (-0.44%)

22% less funds holding

Funds holding: 81 → 63 (-18)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

50% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 30

57% less capital invested

Capital invested by funds: $49.7M → $21.4M (-$28.3M)

Holders
63
Holders Change
-18
Holders Change %
-22.22%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
15
Reduced
22
Closed
30
Calls
$141K
Puts
–
Net Calls
+$141K
Net Calls Change
+$50K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.07M
2
Renaissance Technologies
Renaissance Technologies
New York
+$421K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$259K
4
E
Ergoteles
New York
+$202K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$120K

Top Sellers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$2.19M
2
BlackRock
BlackRock
New York
-$2.01M
3
State Street
State Street
Massachusetts
-$565K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$347K
5
Northern Trust
Northern Trust
Illinois
-$291K
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
76
ProShare Advisors
Maryland
– -$20K -550 Closed
Acadian Asset Management
77
Acadian Asset Management
Massachusetts
– -$14K -385 Closed
AB
78
Amalgamated Bank
New York
– -$9K -231 Closed
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
– -$4.2K -172 -94%
Legal & General Group
80
Legal & General Group
United Kingdom
– -$6K -152 Closed
AIP
81
Ameritas Investment Partners
Nebraska
– -$5K -131 Closed
ACM
82
Aquatic Capital Management
Illinois
– -$4K -95 Closed
Fidelity Investments
83
Fidelity Investments
Massachusetts
– -$1.46K -60 Closed
PHK
84
Point72 Hong Kong
Hong Kong
– -$2K -49 Closed
CAPTRUST Financial Advisors
85
CAPTRUST Financial Advisors
North Carolina
– -$2K -46 Closed
EW
86
Evoke Wealth
California
– -$2K -45 Closed
TFO
87
Tarbox Family Office
California
– -$1K -21 Closed
CS
88
Credit Suisse
Switzerland
– +$49 +2 New
CAL
89
Capital Advisors Ltd
Ohio
– +$73 +3 New
EI
90
Ellevest Inc
New York
– +$73 +3 New
BTI
91
Blue Trust Inc
Georgia
– +$171 +7 New
1 2 3
4

NGNE Hedge Fund Activity: Q2 2022 in Review

63 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2022, worth a combined $21.4M — down 57% from $49.7M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of NGNE and 15 opened new positions — a net loss of 15 holders — while 22 trimmed existing stakes and 15 added.

The largest buyer was Millennium Management, adding an estimated $1.07M. The largest seller was Pictet Asset Management (Switzerland), cutting an estimated $2.19M.

  • 63 institutional investors held Neurogene (NGNE) as of Q2 2022, down from 81 in Q1 2022.
  • Funds reported $21.4M of Neurogene stock for Q2 2022, down 57% quarter-over-quarter.
  • 15 funds opened new Neurogene positions in Q2 2022 and 30 closed out, a net change of -15 holders.
  • The largest Neurogene buyer in Q2 2022 was Millennium Management, an estimated $1.07M added.
  • The largest Neurogene seller in Q2 2022 was Pictet Asset Management (Switzerland), an estimated $2.19M sold.

Based on aggregated 13F filings for Q2 2022.